Adamas Pharmaceuticals

13F holders, Q1 2024 (March 31)
2holders
$0.00avg. 13F price*

At the end of Q1 2024, 2 institutions reported holding Adamas Pharmaceuticals in their 13F filings. The largest holders were Public Employees Retirement System of Ohio ($12) and MAI Capital Management ($0).

Company
Adamas Pharmaceuticals
CUSIP
005CVR014
Latest filing quarter
Q4 2024

History

Number of 13F holders

012 Q1 2024: 2Q1 2024Q2 2024: 2Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024

Total Exit/New Position Q1 2024

No earlier quarter to compare with.

Ownership 2 holders

Public Employees Retirement System of Ohio 0.00% No change 117,000 $12
MAI Capital Management 0.00% Reduce -0.1% 549,557 $0

"% of holder's portfolio" is Adamas Pharmaceuticals's weight in each manager's 13F, not the share of Adamas Pharmaceuticals the manager owns.